Browse > Article
http://dx.doi.org/10.4062/biomolther.2012.20.1.027

Oroxylin A Induces BDNF Expression on Cortical Neurons through Adenosine A2A Receptor Stimulation: A Possible Role in Neuroprotection  

Jeon, Se-Jin (Department of Pharmacology, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Bak, Hae-Rang (Department of Pharmacology, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Seo, Jung-Eun (Department of Pharmacology, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Han, So-Min (Department of Pharmacology, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Lee, Sung-Hoon (Neuroscience Research Center, Institute for Advanced Biomedical Sciences, School of Medicine, Konkuk University)
Han, Seol-Heui (Neuroscience Research Center, Institute for Advanced Biomedical Sciences, School of Medicine, Konkuk University)
Kwon, Kyoung-Ja (Neuroscience Research Center, Institute for Advanced Biomedical Sciences, School of Medicine, Konkuk University)
Ryu, Jong-Hoon (Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyunghee University)
Cheong, Jae-Hoon (Department of Pharmacy, Sahmyook University)
Ko, Kwang-Ho (Department of Pharmacology, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Yang, Sung-Il (Department of Pharmacology, School of Medicine, Konkuk University)
Choi, Ji-Woong (College of Pharmacy, Gachon University of Medicine and Science)
Park, Seung-Hwa (Neuroscience Research Center, Institute for Advanced Biomedical Sciences, School of Medicine, Konkuk University)
Shin, Chan-Young (Neuroscience Research Center, Institute for Advanced Biomedical Sciences, School of Medicine, Konkuk University)
Publication Information
Biomolecules & Therapeutics / v.20, no.1, 2012 , pp. 27-35 More about this Journal
Abstract
Oroxylin A is a flavone isolated from a medicinal herb reported to be effective in reducing the inflammatory and oxidative stresses. It also modulates the production of brain derived neurotrophic factor (BDNF) in cortical neurons by the transactivation of cAMP response element-binding protein (CREB). As a neurotrophin, BDNF plays roles in neuronal development, differentiation, synaptogenesis, and neural protection from the harmful stimuli. Adenosine $A2_A$ receptor colocalized with BDNF in brain and the functional interaction between $A2_A$ receptor stimulation and BDNF action has been suggested. In this study, we investigated the possibility that oroxylin A modulates BDNF production in cortical neuron through the regulation of $A2_A$ receptor system. As expected, CGS21680 ($A2_A$ receptor agonist) induced BDNF expression and release, however, an antagonist, ZM241385, prevented oroxylin A-induced increase in BDNF production. Oroxylin A activated the PI3K-Akt-GSK-$3{\beta}$ signaling pathway, which is inhibited by ZM241385 and the blockade of the signaling pathway abolished the increase in BDNF production. The physiological roles of oroxylin A-induced BDNF production were demonstrated by the increased neurite extension as well as synapse formation from neurons. Overall, oroxylin A might regulate BDNF production in cortical neuron through $A2_A$ receptor stimulation, which promotes cellular survival, synapse formation and neurite extension.
Keywords
Oroxylin A; BDNF; CREB; Adenosine $A2_A$ receptor; CGS21680; ZM241385;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)  (Related Records In Web of Science)
연도 인용수 순위
1 O'Driscoll, C. M. and Gorman, A. M. (2005) Hypoxia induces neurite outgrowth in PC12 cells that is mediated through adenosine A2A receptors. Neuroscience. 131, 321-329.   DOI   ScienceOn
2 Pardon, M. C. (2010) Role of neurotrophic factors in behavioral processes: implications for the treatment of psychiatric and neurodegenerative disorders. Vitam. Horm. 82, 185-200.   DOI
3 Pezet, S. and Malcangio, M. (2004) Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert. Opin. Ther. Targets. 8, 391-399.   DOI   ScienceOn
4 Pousinha, P. A., Diogenes, M. J., Ribeiro, J. A. and Sebastião, A. M. (2006) Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors. Neurosci. Lett. 404, 143-147.   DOI
5 Proll, M. A., Clark, R. B. and Butcher, R. W. (1986) A1 and A2 adenosine receptors regulate adenylate cyclase in cultured human lung fi broblasts. Mol. Cell. Endocrinol. 44, 211-217.   DOI   ScienceOn
6 Rebola, N., Lujan, R., Cunha, R.A. and Mulle, C. (2008) Adenosine A2A receptors are essential for long-term potentiation of NMDAEPSCs at hippocampal mossy fi ber synapses. Neuron. 57, 121-134.   DOI   ScienceOn
7 Sasaki, Y., Welshhans, K., Wen, Z., Yao, J., Xu, M., Goshima, Y., Zheng, J. Q. and Bassell, G. J. (2010) Phosphorylation of zipcode binding protein 1 is required for brain-derived neurotrophic factor signaling of local beta-actin synthesis and growth cone turning. J. Neurosci. 30, 9349-9358.   DOI   ScienceOn
8 Scemes, E., Duval, N. and Meda, P. (2003) Reduced expression of P2Y1 receptors in connexin43-null mice alters calcium signaling and migration of neural progenitor cells. J. Neurosci. 23, 11444-11452.
9 Schmidt, H. D. and Duman, R. S. (2007) The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav. Pharmacol. 18, 391-418.   DOI   ScienceOn
10 Sebastiao, A. M. and Ribeiro, J. A. (2009) Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection. Br. J. Pharmacol. 158, 15-22.   DOI   ScienceOn
11 Shen, W., Wu, B., Zhang, Z., Dou, Y., Rao, Z. R., Chen, Y. R. and Duan, S. (2006) Activity-induced rapid synaptic maturation mediated by presynaptic cdc42 signaling. Neuron. 50, 401-414.   DOI   ScienceOn
12 Shih, H. C., Hsu, C. S. and Yang, L. L. (2009) In vitro study of the tocolytic effect of oroxylin A from Scutellaria baicalensis root. J. Biomed. Sci. 16, 27.   DOI
13 Stafford, M. R., Bartlett, P. F. and Adams, D. J. (2007) Purinergic receptor activation inhibits mitogen-stimulated proliferation in primary neurospheres from the adult mouse subventricular zone. Mol. Cell. Neurosci. 35, 535-548.   DOI   ScienceOn
14 Tebano, M. T., Martire, A., Potenza, R. L., Grò, C., Pepponi, R., Armida, M., Domenici, M. R., Schwarzschild, M. A., Chen, J. F. and Popoli, P. (2008) Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus. J. Neurochem. 104, 279-286.
15 Tebano, M. T., Martire, A., Rebola, N., Pepponi, R., Domenici, M. R., Grò, M. C., Schwarzschild, M. A., Chen, J. F., Cunha, R. A. and Popoli, P. (2005) Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of Nmethyl- D-aspartate effects. J. Neurochem. 95, 1188-1200.   DOI   ScienceOn
16 Terashima, M., Kobayashi, M., Motomiya, M., Inoue, N., Yoshida, T., Okano, H., Iwasaki, N., Minami, A. and Matsuoka, I. (2010) Analysis of the expression and function of BRINP family genes during neuronal differentiation in mouse embryonic stem cell-derived neural stem cells. J. Neurosci. Res. 88, 1387-1393.
17 Tucker, A. L. and Linden, J. (1993) Cloned receptors and cardiovascular responses to adenosine. Cardiovasc. Res. 27, 62-67.   DOI   ScienceOn
18 Angelucci, F., Brenè, S. and Mathe, A. A. (2005) BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry. 10, 345-352.   DOI   ScienceOn
19 Wiese, S., Jablonka, S., Holtmann, B., Orel, N., Rajagopal, R., Chao, M. V. and Sendtner, M. (2007) Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB. Proc. Natl. Acad. Sci. USA. 104, 17210-17215.   DOI   ScienceOn
20 Winckler, B. (2007) BDNF instructs the kinase LKB1 to grow an axon. Cell. 129, 459-460.   DOI   ScienceOn
21 Bartrup, J. T., Moorman, J. M. and Newberry, N. R. (1997) BDNF enhances neuronal growth and synaptic activity in hippocampal cell cultures. Neuroreport. 8, 3791-3794.   DOI   ScienceOn
22 Canals, M., Angulo, E., Casadó, V., Canela, E. I., Mallol, J., Viñals, F., Staines, W., Tinner, B., Hillion, J., Agnati, L., Fuxe, K., Ferré, S., Lluis, C. and Franco, R. (2005) Molecular mechanisms involved in the adenosine A and A receptor-induced neuronal differentiation in neuroblastoma cells and striatal primary cultures. J. Neurochem. 92, 337-348.   DOI   ScienceOn
23 Chen, Y., Yang, L. and Lee, T. J. (2000) Oroxylin A inhibition of lipopolysaccharide- induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. Biochem. Pharmacol. 59, 1445-1457.   DOI   ScienceOn
24 Choi, S. H., Li, Y., Parada, L. F. and Sisodia, S. S. (2009) Regulation of hippocampal progenitor cell survival, proliferation and dendritic development by BDNF. Mol. Neurodegener. 4, 52.   DOI   ScienceOn
25 Chen, Y. C., Shen, S. C., Chen, L. G., Lee, T. J. and Yang, L. L. (2001) Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem. Pharmacol. 61, 1417-1427.   DOI   ScienceOn
26 Cheng, H. C., Shih, H. M. and Chern, Y. (2002) Essential role of cAMPresponse element-binding protein activation by A2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blockage of the MAPK cascade. J. Biol. Chem. 277, 33930-33942.   DOI
27 Cheng, Y., Gidday, J. M., Yan, Q., Shah, A. R. and Holtzman, D. M. (1997) Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann. Neurol. 41, 521-529.   DOI   ScienceOn
28 Chou, S. Y., Lee, Y. C., Chen, H. M., Chiang, M. C., Lai, H. L., Chang, H. H., Wu, Y. C., Sun, C. N., Chien, C. L., Lin, Y. S., Wang, S. C., Tung, Y. Y., Chang, C. and Chern, Y. (2005) CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model. J. Neurochem. 93, 310-320.   DOI   ScienceOn
29 Cowansage, K. K., LeDoux, J. E. and Monfi ls, M. H. (2010) Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr. Mol. Pharmacol. 3, 12-29.   DOI
30 Croll, S. D., Wiegand, S. J., Anderson, K. D., Lindsay, R. M. and Nawa, H. (1994) Regulation of neuropeptides in adult rat forebrain by the neurotrophins BDNF and NGF. Eur. J. Neurosci. 6, 1343-1353.   DOI   ScienceOn
31 Cunha, R. A., Ferre, S., Vaugeois, J. M. and Chen, J. F. (2008) Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr. Pharm. Des. 14, 1512-1524.   DOI   ScienceOn
32 Francesco, A. L., Diego, G., Susanna, G., Giuseppina, L., Amina, W. S., Sergi, F., Rafael, F. and Kjell, F. (2008) Integrative action of receptor mosaics: relevance of receptor topology and allosteric modulators. J. Recept. Signal. Transduct. Res. 28, 543-565.   DOI
33 Diogenes, M. J., Fernandes, C. C., Sebastiao, A. M. and Ribeiro, J. A. (2004) Activation of adenosine A2A receptor facilitates brainderived neurotrophic factor modulation of synaptic transmission in hippocampal slices. J. Neurosci. 24, 2905-2913.   DOI   ScienceOn
34 Flajolet, M., Wang, Z., Futter, M., Shen, W., Nuangchamnong, N., Bendor, J., Wallach, I., Nairn, A. C., Surmeier, D. J. and Greengard, P. (2008) FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity. Nat. Neurosci. 11, 1402-1409.   DOI   ScienceOn
35 Fontinha, B. M., Diógenes, M. J., Ribeiro, J. A. and Sebastião, A. M. (2008) Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine. Neuropharmacology. 54, 924-933.   DOI   ScienceOn
36 Gasiorowski, K., Lamer-Zarawska, E., Leszek, J., Parvathaneni, K., Yendluri, B. B., Błach-Olszewska, Z. and Aliev, G. (2011) Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration? CNS. Neurol. Disord. Drug. Targets. 10, 184-191.   DOI   ScienceOn
37 Han, B. H. and Holtzman, D. M. (2000) BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J. Neurosci. 20, 5775-5781.
38 Hashimoto, K., Shimizu, E. and Iyo, M. (2004) Critical role of brainderived neurotrophic factor in mood disorders. Brain. Res. Brain. Res. Rev. 45, 104-114.   DOI
39 Huang, N. K., Lin, Y. W., Huang, C. L., Messing, R. O. and Chern, Y. (2001) Activation of protein kinase A and atypical protein kinase C by A(2A) adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells. J. Biol. Chem. 276, 13838-13846.
40 Huen, M. S., Leung, J. W., Ng, W., Lui, W. S., Chan, M. N., Wong, J. T. and Xue, H. 5,7-Dihydroxy-6-methoxyfl avone, a benzodiazepine site ligand isolated from Scutellaria baicalensis Georgi, with selective antagonistic properties. Biochem. Pharmacol. 66, 125-132.
41 Ip, N.Y., Li, Y., Yancopoulos, G.D. and Lindsay, R.M. (1993) Cultured hippocampal neurons show response to BDNF, NT-3 and NT-4, but not NGF. J. Neurosci. 13, 3394-3405.
42 Jeon, S. J., Rhee, S. Y., Seo, J. E., Bak, H. R., Lee, S. H., Ryu, J. H., Cheong, J. H., Shin, C. Y., Kim, G. H., Lee, Y. S. and Ko, K. H. (2011) Oroxylin A increases BDNF production by activation of MAPK-CREB pathway in rat primary cortical neuronal culture. Neurosci. Res. 69, 214-222.   DOI   ScienceOn
43 Jiwajinda, S., Santisopasri, V., Murakami, A., Kim, O. K., Kim, H. W., and Ohigashi, H. (2002) Suppressive effects of edible thai plants on superoxide and nitric oxide generation. Asian. Pac. J. Cancer. Prev. 3, 215-223.
44 Kim, D. H., Jeon, S. J., Son, K. H., Jung, J. W., Lee, S., Yoon, B. H., Choi, J. W., Cheong, J. H., Ko, K. H. and Ryu, J. H. (2006) Effect of the fl avonoid, oroxylin A, on transient cerebral hypoperfusioninduced memory impairment in mice. Pharmacol. Biochem. Behav. 85, 658-668.   DOI   ScienceOn
45 Kim, D. H., Jeon, S. J., Son, K. H., Jung, J. W., Lee, S., Yoon, B. H., Lee, J. J., Cho, Y. W., Cheong, J. H., Ko, K. H. and Ryu, J. H. (2007) The ameliorating effect of oroxylin A on scopolamineinduced memory impairment in mice. Neurobiol. Learn. Mem. 87, 536-546.   DOI   ScienceOn
46 Kim, D. H., Kim, S., Jeon, S. J., Son, K. H., Lee, S., Yoon, B. H., Cheong, J. H., Ko, K. H. and Ryu, J. H. (2008) The effects of acute and repeated oroxylin A treatments on Abeta(25-35)-induced memory impairment in mice. Neuropharmacology. 55, 639-647.   DOI   ScienceOn
47 Kobayashi, H., Yokoyama, M., Matsuoka, Y., Omori, M., Itano, Y., Kaku, R., Morita, K. and Ichikawa, H. (2008) Expression changes of multiple brain-derived neurotrophic factor transcripts in selective spinal nerve ligation model and complete Freund's adjuvant model. Brain. Res. 1206, 13-19.   DOI
48 Lindholm, D., Dechant, G., Heisenberg, C. P. and Thoenen, H. (1993) Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamateinduced neurotoxicity. Eur. J. Neurosci. 5, 1455-1464.   DOI   ScienceOn
49 Lee, E. and Son, H. (2009) Adult hippocampal neurogenesis and related neurotrophic factors. BMB. Rep. 42, 239-244.   과학기술학회마을   DOI
50 Lewin, G. R. (1996) Neurotrophins and the specifi cation of neuronal phenotype. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 351, 405-411.   DOI   ScienceOn
51 Lynch, G., Rex, C. S., Chen, L. Y. and Gall, C. M. (2008) The substrates of memory: defects, treatments, and enhancement. Eur. J. Pharmacol. 585, 2-13.   DOI   ScienceOn
52 Mai, L., Jope, R. S. and Li, X. (2002) BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J. Neurochem. 82, 75-83.   DOI   ScienceOn
53 Marty, S., Carroll, P., Cellerino, A., Castrén, E., Staiger, V., Thoenen, H. and Lindholm, D. (1996) Brain-derived neurotrophic factor promotes the differentiation of various hippocampal nonpyramidal neurons, including Cajal-Retzius cells, in organotypic slice cultures. J. Neurosci. 16, 675-687.
54 Moser, A., Liebetrau, A. and Cramer, H. (1991) Adenosine receptorcoupled adenylate cyclase in the caudate nucleus of the rat brain. Neuropharmacology. 30, 769-773.   DOI   ScienceOn
55 Nawa, H., Pelleymounter, M. A. and Carnahan, J. (1994) Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. J. Neurosci. 14, 3751-3765.
56 Noble, E. E., Billington, C. J., Kotz, C.M. and Wang, C. (2011) The lighter side of BDNF. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R1053-1069.   DOI   ScienceOn